Alpa Laboratories Ltd. Share Price

Overview

Alpa Laboratories Ltd. share price is currently ₹48.29, down by - ₹2.93 (5.72%) from its previous closing price of ₹51.22. The share price has declined -20.06% over the past month and declined -44.23% over the past year. The stock's 52-week low and high are ₹45.14 and ₹91.83, respectively. Alpa Laboratories Ltd. has a market capitalisation of ₹ 110.00 Cr. The share price was last updated on 23 Oct 2026, 03:29 PM IST.

Alpa Laboratories Ltd.
Alpa Laboratories Ltd.
ALPA
 ₹0.00
- ₹2.93
5.72%
Healthcare
 ₹0.00(%)1D

Updated: 23 Oct 2026, 03:29:46 pm IST

Market Data

Open Price

 ₹50.20

Prev. Close

 ₹51.22
 ₹48.00

Day Low

 ₹51.03

Day High

 ₹45.14

52 Week Low

 ₹91.83

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryMicro Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

23.22

Sector PE

42.08

PB Ratio

0.55

Sector PB

5.48

EPS

2.08

Dividend Yield

0.00

Today's Volume

14.177 K

5 Day Avg. Volume

13.290 K

PEG Ratio

-1.01

Market Cap.

₹ 110.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Corporate Actions will be available shortly.

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Alpa Laboratories Ltd. 👋

Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
TrueNorth Capital

TrueNorth Capital

7 Dec • 12:33 PM · SEBI-Registered Analyst

INDIGO
Secures Temporary Relief from FDTL Norms to Stabilize Operations

INDIGO
has resumed hiring for its A320 fleet after securing a temporary waiver from the new Flight Duty Time Limitations (FDTL) norms. The move follows unprecedented flight cancellations and mounting pressure to stabilize operations. While the disruption has dented performance metrics, analysts expect limited financial impact due to IndiGo’s scale and market dominance./ On December 5, the Ministry of Civil Aviation placed the new FDTL norms in abeyance for IndiGo until February 10, 2026. The norms, designed to mitigate pilot fatigue, were suspended after over 1,000 flights were cancelled in a single day—the highest in IndiGo’s history. IndiGo immediately restarted recruitment for A320 captains and senior first officers. Eligibility includes Indian nationals or OCI cardholders under 55 (first officers) or 62 (captains), with specific flying hour thresholds. Cabin attendant hiring also opened for female candidates aged 18–27, with relocation flexibility. - Industry Pushback on Waiver Pilot bodies like FIP and ALPA criticized the waiver, citing safety risks and judicial non-compliance. ALPA warned that delaying fatigue protections undermines aviation science and endangers both crew and passengers. - Flight Cancellations and Performance Impact IndiGo’s on-time performance dropped below 4% on December 5, with 96% of flights delayed. Over 3,000 flights have been cancelled since early November, with another 1,500 expected before operations normalize. The CEO aims to restore schedules by December 15. - Financial Impact Expected to Be Contained Analysts estimate cancellations will affect less than 2.5% of quarterly flights. With a winter schedule 6% larger than summer, and total quarterly flights at ~2 lakh, the topline impact is projected at 5–7% only if disruptions persist. Market leadership and scale offer resilience. Would you like a dashboard comparing IndiGo’s operational metrics and hiring trends with peers like Air India, Vistara, and Akasa Air?

See More

Frequently Asked Questions

What is the share price of Alpa Laboratories Ltd.?

What is the market cap of Alpa Laboratories Ltd.?

Should I buy Alpa Laboratories Ltd. stock now?

What is the 52 week high and low of Alpa Laboratories Ltd.?

Is the Alpa Laboratories Ltd. stock good to buy?

Is Alpa Laboratories Ltd. a good buy for the long term?

Is Alpa Laboratories Ltd. overvalued or undervalued?

What is the PE and PB ratio of Alpa Laboratories Ltd.?

Start Now